These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28621224)
21. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023 [TBL] [Abstract][Full Text] [Related]
22. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584 [TBL] [Abstract][Full Text] [Related]
23. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids. Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747 [TBL] [Abstract][Full Text] [Related]
26. miR-375 is highly expressed and possibly transactivated by achaete-scute complex homolog 1 in small-cell lung cancer cells. Zhao H; Zhu L; Jin Y; Ji H; Yan X; Zhu X Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):177-82. PubMed ID: 22172490 [TBL] [Abstract][Full Text] [Related]
27. Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer. Jiang T; Collins BJ; Jin N; Watkins DN; Brock MV; Matsui W; Nelkin BD; Ball DW Cancer Res; 2009 Feb; 69(3):845-54. PubMed ID: 19176379 [TBL] [Abstract][Full Text] [Related]
28. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors. Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905 [TBL] [Abstract][Full Text] [Related]
29. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423 [TBL] [Abstract][Full Text] [Related]
30. An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Borges M; Linnoila RI; van de Velde HJ; Chen H; Nelkin BD; Mabry M; Baylin SB; Ball DW Nature; 1997 Apr; 386(6627):852-5. PubMed ID: 9126746 [TBL] [Abstract][Full Text] [Related]
31. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome. Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450 [TBL] [Abstract][Full Text] [Related]
32. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions]. Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827 [TBL] [Abstract][Full Text] [Related]
33. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer. Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560 [TBL] [Abstract][Full Text] [Related]
34. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features. Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617 [TBL] [Abstract][Full Text] [Related]
35. Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Osada H; Tomida S; Yatabe Y; Tatematsu Y; Takeuchi T; Murakami H; Kondo Y; Sekido Y; Takahashi T Cancer Res; 2008 Mar; 68(6):1647-55. PubMed ID: 18339843 [TBL] [Abstract][Full Text] [Related]
36. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. Nakakura EK; Sriuranpong VR; Kunnimalaiyaan M; Hsiao EC; Schuebel KE; Borges MW; Jin N; Collins BJ; Nelkin BD; Chen H; Ball DW J Clin Endocrinol Metab; 2005 Jul; 90(7):4350-6. PubMed ID: 15870121 [TBL] [Abstract][Full Text] [Related]
37. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas. Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of ANKRD18B in lung cancer. Liu WB; Han F; Jiang X; Yin L; Chen HQ; Li YH; Liu Y; Cao J; Liu JY Mol Carcinog; 2015 Apr; 54(4):312-21. PubMed ID: 24249358 [TBL] [Abstract][Full Text] [Related]
39. Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients. Wang CY; Shahi P; Huang JT; Phan NN; Sun Z; Lin YC; Lai MD; Werb Z Mol Clin Oncol; 2017 Jan; 6(1):7-18. PubMed ID: 28123722 [TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder rats. Chen J; Zacharek A; Li A; Zhang C; Ding J; Roberts C; Lu M; Kapke A; Chopp M Neuroscience; 2006 Aug; 141(2):737-744. PubMed ID: 16730914 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]